Sabba Stephen L 4
4 · LIGAND PHARMACEUTICALS INC · Filed Dec 27, 2022
Insider Transaction Report
Form 4
Sabba Stephen L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-12-22+6,623→ 6,623 totalExercise: $67.03Exp: 2032-12-22→ Common Stock (6,623 underlying)
Footnotes (1)
- [F1]Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.